Heidi Boland1, Maura DiSalvo2, Ronna Fried3, K Yvonne Woodworth4, Timothy Wilens5, Stephen V Faraone6, Joseph Biederman7. 1. Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA. Electronic address: hboland@partners.org. 2. Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA. Electronic address: mdisalvo@partners.org. 3. Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA. Electronic address: rfried@partners.org. 4. Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, MA, USA. Electronic address: kywoodworth@partners.org. 5. Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: twilens@partners.org. 6. Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA. Electronic address: sfaraone@childpsychresearch.org. 7. Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: biederman@helix.mgh.harvard.edu.
Abstract
OBJECTIVE: To conduct a systematic review and meta-analysis of literature from large databases and registries to assess the effects of ADHD medication on associated functional outcomes. STUDY DESIGN: A literature search was performed in PubMed, PsycINFO, MEDLINE, and Web of Science for articles published prior to January 2019. Sample size, age range, country of origin, medication type, number of functional events and non-events, odds ratios and hazard ratios, and means and standard deviations were extracted. Random-effects meta-analyses were conducted for 21 studies examining functional outcomes. RESULTS: 40 articles were included. The majority suggest a robust protective effect of ADHD medication treatment on mood disorders, suicidality, criminality, substance use disorders, accidents and injuries, traumatic brain injuries, motor vehicle crashes, and educational outcomes. Similarly, the meta-analyses demonstrated a protective effect of medication treatment on academic outcomes, accidents and injuries, and mood disorders. CONCLUSIONS: These findings suggest that ADHD medication treatments are associated with decreases in the risks for a wide range of ADHD-associated functional outcomes supporting efforts aimed at early diagnosis and treatment of individuals with ADHD.
OBJECTIVE: To conduct a systematic review and meta-analysis of literature from large databases and registries to assess the effects of ADHD medication on associated functional outcomes. STUDY DESIGN: A literature search was performed in PubMed, PsycINFO, MEDLINE, and Web of Science for articles published prior to January 2019. Sample size, age range, country of origin, medication type, number of functional events and non-events, odds ratios and hazard ratios, and means and standard deviations were extracted. Random-effects meta-analyses were conducted for 21 studies examining functional outcomes. RESULTS: 40 articles were included. The majority suggest a robust protective effect of ADHD medication treatment on mood disorders, suicidality, criminality, substance use disorders, accidents and injuries, traumatic brain injuries, motor vehicle crashes, and educational outcomes. Similarly, the meta-analyses demonstrated a protective effect of medication treatment on academic outcomes, accidents and injuries, and mood disorders. CONCLUSIONS: These findings suggest that ADHD medication treatments are associated with decreases in the risks for a wide range of ADHD-associated functional outcomes supporting efforts aimed at early diagnosis and treatment of individuals with ADHD.
Authors: Timothy E Wilens; Diana W Woodward; Je Deuk Ko; Amy F Berger; Colin Burke; Amy M Yule Journal: J Child Adolesc Psychopharmacol Date: 2022-05-04 Impact factor: 3.031
Authors: Carolina Cuba Bustinza; Ryan E Adams; Angelika H Claussen; Daniel Vitucci; Melissa L Danielson; Joseph R Holbrook; Sana N Charania; Kaila Yamamoto; Nichole Nidey; Tanya E Froehlich Journal: J Atten Disord Date: 2022-04-05 Impact factor: 3.196
Authors: Karen Crawford; Bridie Fitzpatick; Lynn McMahon; Matt Forde; Susanne Miller; Alex McConnachie; Martina Messow; Marion Henderson; Emma McIntosh; Kathleen Boyd; Dennis Ougrin; Phil Wilson; Nicholas Watson; Helen Minnis Journal: Trials Date: 2022-02-07 Impact factor: 2.279